"10.1371_journal.pone.0076060","plos one","2013-09-17T00:00:00Z","Henriette Frikke-Schmidt; Thomas Åskov Pedersen; Christian Fledelius; Grith Skytte Olsen; Marc Hellerstein","Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, California, United States of America; Department of Insulin Biology, Novo Nordisk A/S, Maaloev, Denmark; Department of Insulin Pharmacology, Novo Nordisk A/S, Maaloev, Denmark; KineMed, Inc., Emeryville, California, United States of America","Conceived and designed the experiments: HFS TÅP GSO CF MH. Performed the experiments: HFS. Analyzed the data: HFS. Contributed reagents/materials/analysis tools: MH. Wrote the manuscript: HFS MH. Reviewed the manuscript prior to submission: HFS TÅP GSO CF MH.","The authors declare that the study was funded by Novo Nordisk A/S through which the authors HF-S, TÅP, GSO, and CF all are employees and stakeholders. The insulin used for the experiments has been provided by Novo Nordisk A/S. All Intellectual Property Rights of the current study are owned by University of California Berkeley and there has been no compromise of the objectivity or validity of the data in the manuscript. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Henriette Frikke-Schmidt","HFS",5,TRUE,5,1,1,2,TRUE,TRUE,FALSE,0,NA,FALSE
